Development of adenovirus vectors for the expression of heterologous genes.

No abstract is available for this paper.

• Publication year

  1988

• Venue

  BioTechniques

• Publication date

  1988-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 3078719
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A small deletion distant from a splice or polyadenylation site dramatically alters pre-mRNA processing in region E3 of adenovirus

  1987cited by this paper
• Identification of a novel sequence that governs both polyadenylation and alternative splicing in region E3 of adenovirus.

  1987cited by this paper
• Abundant expression of polyomavirus middle T antigen and dihydrofolate reductase in an adenovirus recombinant

  1987cited by this paper
• Regulation of early adenovirus gene expression.

  1987cited by this paper
• Induced heat shock mRNAs escape the nucleocytoplasmic transport block in adenovirus-infected HeLa cells

  1987cited by this paper
• Cellular promoters incorporated into the adenovirus genome. Effect of viral DNA replication on endogenous and exogenous gene transcription.

  1987cited by this paper
• Adenovirus early region 4 is required for efficient virus particle assembly

  1987cited by this paper
• A short sequence in the COOH-terminus makes an adenovirus membrane glycoprotein a resident of the endoplasmic reticulum

  1987cited by this paper
• A mechanism by which adenovirus virus-associated RNAI controls translation in a transient expression assay

  1987cited by this paper
• Overproduction of polyomavirus middle T antigen in mammalian cells through the use of an adenovirus vector

  1987cited by this paper
• The creation of adenovirus genomes with viable, stable, internal redundancies centered about the E2b region.

  1987cited by this paper
• Adenovirus VAI RNA complexes with the 68 000 Mr protein kinase to regulate its autophosphorylation and activity.

  1987cited by this paper
• The structure and functions of the adenovirus early region 1 proteins.

  1987cited by this paper
• Recombinant adenovirus induces antibody response to hepatitis B virus surface antigen in hamsters.

  1987cited by this paper
• Characterization of middle T antigen expressed by using an adenovirus expression system

  1987cited by this paper
• Growth of 293 cells in suspension culture.

  1987cited by this paper
• Protein IX, a minor component of the human adenovirus capsid, is essential for the packaging of full length genomes.

  1987cited by this paper
• Identification of a repeated sequence element required for efficient encapsidation of the adenovirus type 5 chromosome

  1987cited by this paper
• "E3/19K" protein of adenovirus type 2 inhibits lysis of cytolytic T lymphocytes by blocking cell-surface expression of histocompatibility class I antigens.

  1987cited by this paper
• Cellular transformation by adenovirus type 5 is influenced by the viral DNA polymerase

  1987cited by this paper
• Productive infection of cultured human lymphoid cells by adenovirus

  1987cited by this paper
• Stable transfer of a mouse dihydrofolate reductase gene into a deficient cell line using human adenovirus vector.

  1987cited by this paper
• Mutations in the adenovirus major late promoter: effects on viability and transcription during infection

  1987cited by this paper
• Adenovirus late protein synthesis is resistant to the inhibition of translation induced by poliovirus.

  1987cited by this paper
• Stable gene transfer and tissue‐specific expression of a human globin gene using adenoviral vectors.

  1986cited by this paper
• Development of a helper-independent human adenovirus vector and its use in the transfer of the herpes simplex virus thymidine kinase gene

  1986cited by this paper
• Cellular promoters incorporated into the adenovirus genome: effects of viral regulatory elements on transcription rates and cell specificity of albumin and beta-globin promoters

  1986cited by this paper
• Human adenovirus cloning vectors based on infectious bacterial plasmids.

  1986cited by this paper
• Adenovirus promoters and E1A transactivation.

  1986cited by this paper
• Adenoviral early region 4 is required for efficient viral DNA replication and for late gene expression

  1986cited by this paper
• Template requirements for in vivo replication of adenovirus DNA

  1986cited by this paper
• Downstream sequences affect transcription initiation from the adenovirus major late promoter

  1986cited by this paper
• Viable viruses with deletions in the left inverted terminal repeat define the adenovirus origin of DNA replication.

  1986cited by this paper
• Role of adenovirus type 2 early region 4 in the early-to-late switch during productive infection

  1986cited by this paper
• A mechanism for the control of protein synthesis by adenovirus VA RNAI.

  1986cited by this paper
• Construction of a helper-free recombinant adenovirus that expresses polyomavirus large T antigen

  1986cited by this paper
• Cell-type-specific synthesis of murine immunoglobulin mu RNA from an adenovirus vector

  1986cited by this paper
• The adenovirus E1B-55K transforming polypeptide modulates transport or cytoplasmic stabilization of viral and host cell mRNAs

  1986cited by this paper
• Cellular promoters incorporated into the adenovirus genome: cell specificity of albumin and immunoglobulin expression

  1986cited by this paper
• In vivo identification of sequence elements required for normal function of the adenovirus major late transcriptional control region.

  1986cited by this paper
• Human erythropoietin gene: high level expression in stably transfected mammalian cells and chromosome localization.

  1986cited by this paper
• Effect of the tripartite leader on synthesis of a non-viral protein in an adenovirus 5 recombinant.

  1985cited by this paper
• In vitro and in vivo synthesis of the hepatitis B virus surface antigen and of the receptor for polymerized human serum albumin from recombinant human adenoviruses.

  1985cited by this paper
• An adenovirus type 2 glycoprotein blocks cell surface expression of human histocompatibility class I antigens.

  1985cited by this paper
• Overproduction of the protein product of a nonselected foreign gene carried by an adenovirus vector.

  1985cited by this paper
• Adenovirus VA RNAI mediates a translational stimulation which is not restricted to the viral mRNAs.

  1985cited by this paper
• Identification of the components necessary for adenovirus translational control and their utilization in cDNA expression vectors.

  1985cited by this paper
• Impaired intracellular transport of class I MHC antigens as a possible means for adenoviruses to evade immune surveillance.

  1985cited by this paper
• Adenovirus early region 4 encodes functions required for efficient DNA replication, late gene expression, and host cell shutoff

  1985cited by this paper
• Expression of hepatitis B surface antigen with a recombinant adenovirus.

  1985cited by this paper
• Adenovirus E1B proteins are required for accumulation of late viral mRNA and for effects on cellular mRNA translation and transport

  1985cited by this paper
• The origin of adenovirus DNA replication: minimal DNA sequence requirement in vivo.

  1985cited by this paper
• Sequence-independent autoregulation of the adenovirus type 5 E1A transcription unit

  1985cited by this paper
• Origin of adenovirus DNA replication. Role of the nuclear factor I binding site in vivo.

  1985cited by this paper
• Construction of nondefective adenovirus type 5 bearing a 2.8-kilobase hepatitis B virus DNA near the right end of its genome

  1985cited by this paper
• Transfer of genes into hematopoietic cells using recombinant DNA viruses.

  1985cited by this paper
• An adenovirus vector system used to express polyoma virus tumor antigens.

  1985cited by this paper
• Efficient transformation of human fibroblasts by adenovirus-simian virus 40 recombinants

  1984cited by this paper
• 19-kDa tumor antigen coded by early region E1b of adenovirus 2 is required for efficient synthesis and for protection of viral DNA.

  1984cited by this paper
• Mutations in the gene encoding the adenovirus early region 1B 19,000-molecular-weight tumor antigen cause the degradation of chromosomal DNA

  1984cited by this paper
• Adenovirus early region 1B 58,000-dalton tumor antigen is physically associated with an early region 4 25,000-dalton protein in productively infected cells

  1984cited by this paper
• Replication of adenovirus mini-chromosomes.

  1984cited by this paper
• Covalently closed circles of human adenovirus DNA are infectious.

  1984cited by this paper
• Rescue of functional replication origins from embedded configurations in a plasmid carrying the adenovirus genome

  1984cited by this paper
• Adenovirus type 5 early region 1b gene product is required for efficient shutoff of host protein synthesis

  1984cited by this paper
• Shut-off of actin biosynthesis in adenovirus serotype-2-infected cells.

  1984cited by this paper
• Infection of eucaryotic cells by helper-independent recombinant adenoviruses: early region 1 is not obligatory for integration of viral DNA

  1984cited by this paper
• The adenovirus early proteins.

  1984cited by this paper
• Adenovirus early region 1A protein activates transcription of a nonviral gene introduced into mammalian cells by infection or transfection.

  1984cited by this paper
• Adenovirus tripartite leader sequence enhances translation of mRNAs late after infection.

  1984cited by this paper
• Deletion of the gene encoding the adenovirus 5 early region 1b 21,000-molecular-weight polypeptide leads to degradation of viral and host cell DNA

  1984cited by this paper
• Expression of dihydrofolate reductase, and of the adjacent EIb region, in an Ad5-dihydrofolate reductase recombinant virus.

  1984cited by this paper
• Association between transplantation antigens and a viral membrane protein synthesized from a mammalian expression vector.

  1983cited by this paper
• The genetic analysis of recombination using adenovirus overlapping terminal DNA fragments.

  1983cited by this paper
• Effect of adenovirus on metabolism of specific host mRNAs: transport control and specific translational discrimination

  1983cited by this paper
• Covalently closed circles of adenovirus 5 DNA

  1983cited by this paper
• Translational control of SV40 T antigen expressed from the adenovirus late promoter.

  1983cited by this paper
• Complex formation of class I transplantation antigens and a viral glycoprotein.

  1983cited by this paper
• Generation of adenovirus by transfection of plasmids.

  1983cited by this paper
• A cell line that supports the growth of a defective early region 4 deletion mutant of human adenovirus type 2.

  1983cited by this paper
• The adenovirus type 5 E1A transcriptional control region contains a duplicated enhancer element.

  1983cited by this paper
• The infectivity of adenovirus genomes lacking DNA sequences from their left-hand termini.

  1982cited by this paper
• Mapping of an adenovirus function involved in the inhibition of DNA degradation

  1982cited by this paper
• An adenovirus glycoprotein binds heavy chains of class I transplantation antigens from man and mouse

  1982cited by this paper
• Adenovirus VAI RNA is required for efficient translation of viral mRNAs at late times after infection.

  1982cited by this paper
• Regulation of adenovirus-2 gene expression at the level of transcriptional termination and RNA processing

  1981cited by this paper
• Cloning of a DNA fragment from the left-hand terminus of the adenovirus type 2 genome and its use in site-directed mutagenesis

  1981cited by this paper
• Promoters and heterogeneous 5' termini of the messenger RNAs of adenovirus serotype 2.

  1981cited by this paper
• Construction of an adenovirus-SV40 recombinant producing SV40 T antigen from an adenovirus late promoter.

  1981cited by this paper
• Adenovirus type 5 virions can be assembled in vivo in the absence of detectable polypeptide IX

  1981cited by this paper
• Transcripts from the adenovirus-2 major late promoter yield a single early family of 3' coterminal mRNAs and five late families.

  1980cited by this paper
• The major late adenovirus type-2 transcription unit: termination is downstream from the last poly(A) site.

  1979cited by this paper
• Inhibition of HeLa cell protein synthesis during adenovirus infection. Restriction of cellular messenger RNA sequences to the nucleus.

  1979cited by this paper
• Isolation of adenovirus type 5 host range deletion mutants defective for transformation of rat embryo cells.

  1979cited by this paper
• Physical mapping of a large-plaque mutation of adenovirus type 2

  1979cited by this paper
• Molecular association between transplantation antigens and cell surface antigen in adenovirus-transformed cell line.

  1978cited by this paper
• RNA structures near poly(A) of adenovirus-2 late messenger RNAs.

  1978cited by this paper
• Isolation of deletion and substitution mutants of adenovirus type 5.

  1978cited by this paper
• A map of cytoplasmic RNA transcripts from lytic adenovirus type 2, determined by electron microscopy of RNA:DNA hybrids.

  1977cited by this paper
• Characteristics of a human cell line transformed by DNA from human adenovirus type 5.

  1977cited by this paper

• A data-driven cartography of NSCLC vaccine research: Quantifying the paradigm shift toward immuno-oncology combination therapies

  2026cites this paper
• Advanced Nanomedicine Delivery Systems for Cardiovascular Diseases: Viral and Non-Viral Strategies in Targeted Therapy

  2025cites this paper
• Adenoviral Vector System: A Comprehensive Overview of Constructions, Therapeutic Applications and Host Responses

  2024cites this paper
• Evolving Horizons: Adenovirus Vectors’ Timeless Influence on Cancer, Gene Therapy and Vaccines

  2023cites this paper
• Considering the potential for gene-based therapy in prostate cancer

  2021cites this paper
• Pre-Clinical and Clinical Applications of Small Interfering RNAs (siRNA) and Co-Delivery Systems for Pancreatic Cancer Therapy

  2021cites this paper
• Rapid and inexpensive purification of adenovirus vectors using an optimised aqueous two-phase technology

  2021cites this paper
• Novel role of xanthine oxidase-dependent H2O2 production in 12/15-lipoxygenase-mediated de novo lipogenesis, triglyceride biosynthesis and weight gain

  2021cites this paper
• Adenovirus Vector

  2020cites this paper
• A review of 65 years of human adenovirus seroprevalence

  2019cites this paper
• State‐of‐the‐art human adenovirus vectorology for therapeutic approaches

  2019cites this paper
• Novel Vector Construction Based on Alternative Adenovirus Types via Homologous Recombination

  2018cites this paper
• RNAAGENTS TARGETING VEGF

  2017cites this paper
• Targeting strategies of adenovirus-mediated gene therapy and virotherapy for prostate cancer

  2017cites this paper
• DECREASING GENE EXPRESSION IN A MAMMALIAN SUBJECT IN VIVO VIA AAV-MEDIATED RNA EXPRESSION CASSETTE TRANSFER BACKGROUND OF INVENTION

  2017cites this paper
• Novel p53 therapies for head and neck cancer

  2016cites this paper
• Therapy of arthritis by gene transfer

  2016cites this paper
• Brain-derived neurotrophic factor protects rat cerebral cortical neurons from intermittent hypoxia in vitro

  2016cites this paper
• Replicating Single-Cycle Adenovirus Vectors Generate Amplified Influenza Vaccine Responses

  2016cites this paper
• Gene therapy for metabolic diseases

  2016cites this paper
• Application of conditionally replicating adenoviruses in tumor early diagnosis technology, gene-radiation therapy and chemotherapy

  2016cites this paper
• Efficient construction of recombinant adenovirus expression vector of the Qinchuan cattle LYRM1 gene.

  2015cites this paper
• The role of adenoviral capsid protein VI in cell cycle modulation

  2014cites this paper
• A mammalian expression system for high throughput antibody screening.

  2013cites this paper
• Current standing and frontiers of gene therapy for meningiomas.

  2013cites this paper
• ETHANOL REGULATION OF GLUCOCORTICOID RESPONSIVE GENES

  2013cites this paper
• Comparison of Prostate-Specific Promoters and the Use of PSP-Driven Virotherapy for Prostate Cancer

  2013cites this paper
• 12/15-Lipoxygenase Mediates High-fat Diet-induced Endothelial Tight Junction Disruption and Monocyte Transmigration

  2013cites this paper
• c-Cbl shRNA-expressing adenovirus sensitizes TRAIL-induced apoptosis in prostate cancer DU-145 through increases of DR4/5

  2013cites this paper
• A mouse model for HIV-1 entry

  2012cites this paper
• Novel Role of Proline-Rich Nonreceptor Tyrosine Kinase 2 in Vascular Wall Remodeling After Balloon Injury

  2012cites this paper
• Adenovirus-based gene therapy approaches for hemophilia B

  2012cites this paper
• Role of Sirtuin 1 in the Regulation of Hepatic Gene Expression by Thyroid Hormone*

  2012cites this paper
• Functional studies on factor VIII variants containing different lengths of the B-domain AND The construction of a new helper vector for the production of helper-dependent

  2012cites this paper
• Prostate Cancer-Specific and Potent Antitumor Effect of a DD3-Controlled Oncolytic Virus Harboring the PTEN Gene

  2012cites this paper
• Combination of radiotherapy and adenovirus-mediated p53 gene therapy for MDM2-overexpressing hepatocellular carcinoma.

  2012cites this paper
• Gene Therapy for Metabolic Diseases 1

  2012cites this paper
• Criteria for the Design and Biological Characterization of Radiolabeled Peptide-Based Pharmaceuticals

  2012cites this paper
• Characterisation of Subsidiary Pacemaker Tissue in an Ex Vivo Model of Sick Sinus Syndrome and its Utility for Biopacemaking.

  2011cites this paper
• Delivery Strategies for RNAi to the Nervous System

  2011cites this paper
• Gene Therapy for Von Willebrand Disease

  2011cites this paper
• Generation of a replication-deficient recombinant human adenovirus type 35 vector using bacteria-mediated homologous recombination.

  2011cites this paper
• Recombinant adenovirus‐mediated human telomerase reverse transcriptase gene can stimulate cell proliferation and maintain primitive characteristics in bovine mammary gland epithelial cells

  2011cites this paper
• Chapter 2 Gene Delivery to Cardiovascular Tissue

  2011cites this paper
• Development of adenovirus hybrid vectors for Sleeping Beauty transposition in large mammals.

  2011cites this paper
• Introduction to viral vectors.

  2011cites this paper
• 15-Lipoxygenase-1-enhanced Src-Janus Kinase 2-Signal Transducer and Activator of Transcription 3 Stimulation and Monocyte Chemoattractant Protein-1 Expression Require Redox-sensitive Activation of Epidermal Growth Factor Receptor in Vascular Wall Remodeling*

  2011cites this paper
• Embryonic Stem Cells: Introducing Exogenous Regulators into Embryonic Stem Cells

  2011cites this paper
• Fundamentals of Molecular Biology and Gene Therapy

  2010cites this paper
• The potential of a novel Adenovirus vector for vaccination.

  2010cites this paper
• Retargeting Adenovirus for Cancer Gene Therapy

  2010cites this paper
• Src-dependent STAT-3-mediated Expression of Monocyte Chemoattractant Protein-1 Is Required for 15(S)-Hydroxyeicosatetraenoic Acid-induced Vascular Smooth Muscle Cell Migration*

  2009cites this paper
• Adenovirus-mediated cancer gene therapy and virotherapy (Review).

  2009cites this paper
• A Role for Gab1/SHP2 in Thrombin Activation of PAK1: Gene Transfer of Kinase-Dead PAK1 Inhibits Injury-Induced Restenosis

  2009cites this paper
• Construction of adenoviruses and retroviruses of recombinant iron metabolism genes and their application in the studies on iron metabolism

  2009cites this paper
• CREB‐MEDIATED IL‐6 EXPRESSION IS REQUIRED FOR 15(S)‐HYDROXYEICOSATETRAENOIC ACID‐INDUCED VASCULAR SMOOTH MUSCLE CELL MIGRATION

  2009cites this paper
• The 15(S)-hydroxyeicosatetraenoic acid-induced angiogenesis requires Janus kinase 2-signal transducer and activator of transcription-5B-dependent expression of interleukin-8.

  2009cites this paper
• Suppression of adenoviral-induced host immune response by TGFβ1 expression

  2009cites this paper
• Transcriptionally regulated, prostate-targeted gene therapy for prostate cancer.

  2009cites this paper
• Cyclin D1 Is a Bona Fide Target Gene of NFATc1 and Is Sufficient in the Mediation of Injury-induced Vascular Wall Remodeling*

  2009cites this paper
• IRF3 Inhibition by Rotavirus NSP1 Is Host Cell and Virus Strain Dependent but Independent of NSP1 Proteasomal Degradation

  2009cites this paper
• Functional organization of the major late transcriptional unit of canine adenovirus type 2.

  2009cites this paper
• Gene Delivery to Cardiovascular Tissue

  2009cites this paper
• A novel role for activating transcription factor-2 in 15(S)-hydroxyeicosatetraenoic acid-induced angiogenesis** This work was supported by a grant (EY014856) from the National Eye Institute/National Institutes of Health. Published, JLR Papers in Press, October 10, 2008

  2009cites this paper
• Development of targeted gene delivery vectors to assess cardiac overexpresion of ACE2 in vivo

  2008cites this paper
• The tumorigenicity diversification in human embryonic kidney 293 cell line cultured in vitro.

  2008cites this paper
• Gene therapy methods in bone and joint disorders

  2007cites this paper
• 15(S)-HETE production in human retinal microvascular endothelial cells by hypoxia: Novel role for MEK1 in 15(S)-HETE induced angiogenesis.

  2007cites this paper
• An Essential Role for gp130 in Neointima Formation Following Arterial Injury

  2007cites this paper
• Heme oxygenase -1 gene therapy: recent advances and therapeutic applications.

  2007cites this paper
• Adenoviral vectors for gene therapy

  2007cites this paper
• Suppression of breast cancer metastasis through the inhibition of VEGF-mediated tumor angiogenesis.

  2007cites this paper
• Overcoming maternal antibody interference by vaccination with human adenovirus 5 recombinant viruses expressing the hemagglutinin and the nucleoprotein of swine influenza virus.

  2006cites this paper
• AWARD NUMBER: W81XWH-04-1-0800 TITLE: A Dual-Action Armed Replicating Adenovirus for the Treatment of Osteoblastic Bone Metastases of Prostate Cancer

  2006cites this paper
• Construction and Propagation of Human Adenovirus Vectors

  2006cites this paper
• Gene therapeutics: the future of brain tumor therapy?

  2006cites this paper
• Fibroblast Growth Factor-2 Is a Downstream Mediator of Phosphatidylinositol 3-Kinase-Akt Signaling in 14,15-Epoxyeicosatrienoic Acid-induced Angiogenesis*

  2006cites this paper
• Neuroprotection of adenoviral-vector-mediated GDNF expression against kainic-acid-induced excitotoxicity in the rat hippocampus.

  2006cites this paper
• Transposon-Assisted Cloning and Traceless Mutagenesis of Adenoviruses: Development of a Novel Vector Based on SpeciesD

  2006cites this paper
• A novel and simple method for construction of recombinant adenoviruses

  2006cites this paper
• Combinatorial cancer immunotherapy.

  2006cites this paper
• Cell Cycle Arrest and Inhibition of Tumor Cell Proliferation by the pl 6 WK 4 Gene Mediated by an Adenovirus Vector 1

  2006cites this paper
• Adenovirus-Mediated p53 Treatment Enhances Photodynamic Antitumor Response

  2006cites this paper
• Reversal of the phenotype by K-rasval12 silencing mediated by adenovirus-delivered siRNA in human pancreatic cancer cell line Panc-1.

  2005cites this paper
• Recombinant viruses as vaccines against viral diseases.

  2005cites this paper
• Helper-Dependent Adenoviral Vectors for Gene Therapy

  2005cites this paper
• Modifying xenogeneic immune recognition and engraftment by genetic engineering

  2005cites this paper
• NONVIRAL GENE DELIVERY: USING POLYMER AND PEPTIDE TO DEVELOP SAFE AND CELL-SPECIFIC GENE VECTORS ELIZABETH LUO SZE E NATIONAL UNIVERSITY OF SINGAPORE 2004 NONVIRAL GENE DELIVERY: USING POLYMER AND PEPTIDE TO DEVELOP SAFE AND CELL-SPECIFIC GENE VECTORS

  2005cites this paper
• 15(S)-hydroxyeicosatetraenoic acid induces angiogenesis via activation of PI3K-Akt-mTOR-S6K1 signaling.

  2005cites this paper
• Blockade of Nuclear Factor of Activated T Cells Activation Signaling Suppresses Balloon Injury-induced Neointima Formation in a Rat Carotid Artery Model*

  2005cites this paper
• Short Communication Experimental Inoculation of Heifers with Bovine Adenovirus Type 3

  2005cites this paper
• A phase I study of Adp53 (INGN 201; ADVEXIN) for patients with platinum- and paclitaxel-resistant epithelial ovarian cancer.

  2004cites this paper
• Gene therapy for muscular disease.

  2004cites this paper
• Transient overexpression of kappa and mu opioid receptors using recombinant adenovirus vectors.

  2004cites this paper
• Treatment of cystic fibrosis based on understanding CFTR

  2004cites this paper
• Novel adenoviral vectors coding for GFP-tagged wtCFTR and ΔF508-CFTR: characterization of expression and electrophysiological properties in A549 cells

  2004cites this paper
• Design, synthesis and preclinical evaluation of radiolabeled peptides for diagnosis and therapy.

  2004cites this paper
• Targeting melanoma inhibitor of apoptosis protein with cancer immunotherapy

  2004cites this paper
• Delivery of adenoviral DNA to mouse liver.

  2004cites this paper
• Adenovirus-mediated gene delivery: an overview.

  2004cites this paper